Basis: FMP quote price / unrounded FMP forward EPS in the trading currency, available after its recorded retrieval time. Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is N/A as of 2026-10-06T15:57:10.927Z.
Consensus retrieved: 2026-10-06T13:48:56.408Z. This records retrieval, including cache reads, rather than vendor publication. The calculation uses the separately dated price and estimate available at its as-of time.
Calculation as of: 2026-10-06T15:57:10.927Z.
Quote observation: 2026-10-06T15:54:41.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 5a8aae8e93f82a899e51ff603ce0499f2ee8a4244ac8b174beef8711f00adb15
Forward PE Ratio (N/A) = Dated Quote Price ($1.73) / Consensus Forward EPS ($-0.47)
FORWARD PE RATIO
N/A
Spectral AI, Inc.
Market Cap
$54.90M
Forward PE Ratio
N/A
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| Spectral AI, Inc. (MDAI) | $54.90M | N/A |
| Aldeyra The (ALDX)vs › | $54.48M | N/A |
| ImageneBio Inc (IMA)vs › | $53.80M | N/A |
| OKYO Pharma Limited (OKYO)vs › | $56.98M | N/A |
| NOMAD Power Solutions, Inc. (NMAD)vs › | $52.64M | N/A |
| Dogwood Therapeutics, Inc. (DWTX)vs › | $52.46M | N/A |
| Boundless Bio, Inc. (BOLD)vs › | $57.76M | N/A |
| Eloxx Pharmaceuticals, Inc. (ELOX)vs › | $51.54M | N/A |
| eXoZymes, Inc. (EXOZ)vs › | $51.42M | N/A |
| Rani Therapeutics Holdings, Inc. (RANI)vs › | $51.36M | N/A |
Trailing P/E
N/A
reported TTM EPS
Forward P/E
N/A
consensus EPS · fiscal year ending 2026-12-31
At the dated quote price of $1.73, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.
| Fiscal year end | Consensus EPS | Estimate range | Analysts | Implied P/E |
|---|---|---|---|---|
| 2026-12-31 | $-0.47 | $-0.48 – $-0.44 | 2 | n/m |
| 2027-12-31 | $-0.31 | $-0.38 – $-0.24 | 2 | n/m |
| 2028-12-31 | $-0.29 | $-0.34 – $-0.24 | 1 | n/m |
Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
